Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

3D Cell Culture Technologies Global Market Report 2022: Industry Expected to Reach $4.71 Billion in 2026 at a CAGR of 18.5%. - ResearchAndMarkets.com


The "3D Cell Culture Technologies Global Market Report 2022, By Type, By End Users, By Scaffold-based, By Scaffold-free, By Application" report has been added to ResearchAndMarkets.com's offering.

The global 3D cell culture technologies market is expected to grow from $2.03 billion in 2021 to $2.39 billion in 2022 at a compound annual growth rate (CAGR) of 18.0%. The market is expected to reach $4.71 billion in 2026 at a CAGR of 18.5%.

The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.

The main types of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. The 3D bioreactors are small plastic cylinder chambers designed specifically for growing cells in three dimensions. The various scaffold-based technologies include hydrogels, polymeric scaffolds, micropatterned surface microplates and the different scaffold-free technologies are hanging drop microplates, spheroid microplates, microfluidic 3d cell culture, magnetic levitation and 3D bioprinting.

The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation.

3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. According to the U.S. government information on organ donation and transplantation, 39,718 transplants were performed in 2019 and above 109,000 people are waiting for the transplant as of September 2020.

The possibility of contaminating the cells is restricting the 3D Cell Culture technologies market. Contamination of the cell culture refers to the presence of bacteria, moulds, yeasts, viruses, and mycoplasma that can adversely affect the cell culture. Contamination usually occurs when the cells are mishandled or due to the lack of adequate care, as a result the process of regeneration may get affected.

According to a study conducted by Yale and Tuff's university, it was found that 3D cultures are more complex than 2D cell cultures and they require a more controlled cellular environment in order to mimic structures for tissue or organ transplants. Therefore, probability of cell culture contamination is relatively higher in 3D cell cultures.

Implementing the latest technology is the latest trend in the 3D Cell culture market. For example, various companies have adopted one such advancement into the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment.

The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek's 3D cell expansion system to be used as a medical device. It also approved Biotek's Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA approved implants and drug delivery devices.

Key Topics Covered:

1. Executive Summary

2. 3D Cell Culture Technologies Market Characteristics

3. 3D Cell Culture Technologies Market Trends And Strategies

4. Impact Of COVID-19 On 3D Cell Culture Technologies

5. 3D Cell Culture Technologies Market Size And Growth

5.1. Global 3D Cell Culture Technologies Historic Market, 2016-2021, $ Billion

5.2. Global 3D Cell Culture Technologies Forecast Market, 2021-2026F, 2031F, $ Billion

6. 3D Cell Culture Technologies Market Segmentation

7. 3D Cell Culture Technologies Market Regional And Country Analysis

8. Asia-Pacific 3D Cell Culture Technologies Market

9. China 3D Cell Culture Technologies Market

10. India 3D Cell Culture Technologies Market

11. Japan 3D Cell Culture Technologies Market

12. Australia 3D Cell Culture Technologies Market

13. Indonesia 3D Cell Culture Technologies Market

14. South Korea 3D Cell Culture Technologies Market

15. Western Europe 3D Cell Culture Technologies Market

16. UK 3D Cell Culture Technologies Market

17. Germany 3D Cell Culture Technologies Market

18. France 3D Cell Culture Technologies Market

19. Eastern Europe 3D Cell Culture Technologies Market

20. Russia 3D Cell Culture Technologies Market

21. North America 3D Cell Culture Technologies Market

22. USA 3D Cell Culture Technologies Market

23. South America 3D Cell Culture Technologies Market

24. Brazil 3D Cell Culture Technologies Market

25. Middle East 3D Cell Culture Technologies Market

26. Africa 3D Cell Culture Technologies Market

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/dbz3ym


These press releases may also interest you

at 07:07
At least 5% of Americans suffer from chronic low back pain. [1] Over $630 billion is spent annually on costs to society [2], and chiropractic care is essential in managed post-surgical spinal pain [3] and scoliosis [4]. To prepare clinicians...

at 07:00
Ziegler is pleased to announce the successful closing of Shenandoah Valley Westminster-Canterbury's $71,000,000 Series 2022A and 2022B Bonds for the Senior Living Finance Practice. Shenandoah Valley Westminster-Canterbury (SVWC) is a Virginia...

12 aoû 2022
The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class action lawsuit seeking to represent purchasers of LifeStance Health Group, Inc. common stock issued in connection with LifeStance Health's June 10, 2021 initial...

12 aoû 2022
An arbitrator issued a decision today in a dispute between Daiichi Sankyo Company, Ltd. and Seagen, Inc., denying all claims made by Seagen. Specifically, Daiichi Sankyo retains all patent rights to its antibody drug conjugate (ADC) technology and...

12 aoû 2022
Core One Labs Inc. , , (the "Company" or "Core One") is pleased to announce that scientists at its wholly-owned subsidiary Awakened Biosciences Inc. ("Awakened") have successfully produced a precursor that can be...

12 aoû 2022
Following the passage of the Inflation Reduction Act, Peter L. Saltonstall, President and CEO, the National Organization for Rare Disorders (NORD), issued the following statement:...



News published on 7 july 2022 at 06:25 and distributed by: